Sugar has become virtually inescapable in today’s world, sneaking its way from the aggressive marketing of colorful candies into daily staples like ketchup, salad dressing, and even protein powder7. Alongside this saccharine surge, humanity faces an escalating crisis: Type 2 diabetes. At its core, diabetes occurs when your cells become resistant to insulin, leaving excess glucose trapped in your bloodstream. However, high blood sugar is far more than an annoying number on a monitor; much like the legendary Trojan Horse, it is a clever distraction hiding a much bigger threat inside.
On the surface, diabetes looks like an isolated issue managed simply by watching what you eat, but behind that quiet exterior, chronic high blood sugar acts like microscopic sandpaper on your blood vessels, triggering silent, systemic inflammation throughout your body4. Your kidneys are usually among the first major targets: high blood sugar forces their delicate filters to work under extreme, unnatural pressure, causing tissue scarring and protein leakage into your urine3.
According to clinical consensus from the American Diabetes Association and Kidney Disease: Improving Global Outcomes, up to 40% of people with diabetes eventually develop Chronic Kidney Disease (CKD), often sliding toward kidney failure without feeling a single warning sign1. Simultaneously, diabetes launches a second silent attack on your liver. When your body stops responding to insulin properly, excess fat floods into liver cells, leading to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD, formerly known as NAFLD)5. Over time, this trapped fat causes cellular toxicity, inflammation, and permanent liver scarring6. With guidelines from Diabetes Canada and the American Association for the Study of Liver Diseases indicating that up to 70% of adults with Type 2 diabetes concurrently suffer from MASLD2.
Think about it, how often do we treat high blood sugar as an isolated problem? The most dangerous reality of both CKD and MASLD is that they are completely asymptomatic in their early stages, meaning you will not feel pain until significant damage has already been done. That is why proactive medical screening including routine HbA1c tests for average blood sugar, estimated glomerular filtration rate (eGFR) and urine protein checks for kidney health, and liver enzyme panels is so vital3,6. Recognizing diabetes as a gateway disease is the only way to catch these silent threats early and protect your organs before damage becomes permanent, so don't wait until it's too late to speak with your doctor and get screened today.
References:
1de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022). Diabetes management in chronic kidney disease: A consensus report by the American diabetes association (ADA) and kidney disease: Improving global outcomes (KDIGO). Diabetes Care, 45(12). https://doi.org/10.2337/dci22-0027
2Diabetes Canada | clinical practice guidelines. (2016). Diabetes.Ca. https://guidelines.diabetes.ca/cpg/chapter42
3Jha, R., Lopez-Trevino, S., Kankanamalage, H. R., & Jha, J. C. (2024). Diabetes and renal complications: An overview on pathophysiology, biomarkers and therapeutic interventions. Biomedicines, 12(5), 1098–1098. https://doi.org/10.3390/biomedicines12051098
4Nguyen, D. V., Shaw, L. C., & Grant, M. B. (2012). Inflammation in the pathogenesis of microvascular complications in diabetes. Frontiers in Endocrinology, 3, 170. https://doi.org/10.3389/fendo.2012.00170
5Rinella, M. E., Lazarus, J. V., Vlad Ratziu, Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Juan Pablo Arab, Arrese, M., Bataller, R., Ulrich Beuers, Boursier, J., Elisabetta Bugianesi, Byrne, C., Castro, G. E., Chowdhury, A., Cortez-Pinto, H., … Newsome, P. N. (2023). A multi-society Delphi consensus statement on new fatty liver disease nomenclature. 101133–101133. https://doi.org/10.1016/j.aohep.2023.101133
6Miller, D. M., McCauley, K. F., & Dunham‐Snary, K. J. (2025). Metabolic dysfunction‐associated steatotic liver disease (MASLD): Mechanisms, clinical implications and therapeutic advances. Endocrinology, Diabetes &Amp; Metabolism, 8(6). https://doi.org/10.1002/edm2.70132
7U.S. Department of Agriculture (USDA), & Centers for Disease Control and Prevention (CDC). (n.d.). Dietary guidelines for americans. In FoodData Central.